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Background and purpose   Giant cell tumors (GCTs) of bone 
rarely affect the pelvis. We report on 20 cases that have been 
treated at our institution during the last 20 years. 
Methods   20 patients with histologically benign GCT of the 
pelvis were included in this study. 9 tumors were primarily located 
in the iliosacral area, 6 in the acetabular area, and 5 in the ischio-
pubic area. 8 patients were treated by intralesional curettage and 
6 by intralesional resection with additional curettage of the mar-
gins. 3 patients with iliacal tumors were treated by wide resection. 
2 patients were treated by a combination of external beam irradi-
ation and surgery, and 1 patient solely by irradiation. In addition, 
9 patients received selective arterial embolization one day before 
surgery. Of the 6 patients with acetabular tumors, 1 secondarily 
received an endoprosthesis and 1 was primarily treated by hip 
transposition. The patients were followed for a median time of 3 
(1–11) years.
Results   1 patient with a pubic tumor developed a local recur-
rence 1 year after intralesional resection and additional curettage 
of the margins. The recurrence presented as a small soft tissue 
mass within the scar tissue of the gluteal muscles and was treated 
by resection. No secondary sarcoma was detected and none of the 
patients developed pulmonary metastases or multicentricity. No 
major complication occurred during surgery. 
Interpretation   We conclude that most GCTs of the pelvis can 
be treated by intralesional procedures. For tumors of the iliac 
wing, wide resection can be an alternative. Surgical treatment 
of tumors affecting the acetabular region often results in func-
tional impairment. Pre-surgical selective arterial embolization 




The most commonly recommended treatment for giant cell 
tumors (GCTs) of bone consists of intralesional procedures 
such as curettage, and filling of the defect either with bone 
grafts or bone cement. The local recurrence rate depends on 
the surgical treatment and can be up to 40% (Persson et al. 
1984, Campanacci et al. 1987, Blackley et al. 1999, Malek et 
al. 2006, Kivioja et al. 2008). A recent study has shown that 
the lowest rates in local recurrence (approximately 10%) are 
achieved by intralesional curettage followed by a combination 
of different adjuncts such as high-speed burring, lavage with 
hydrogen peroxide (H2O2), and bone cement packing (poly-
methyl methacrylate; PMMA) (Balke et al. 2008b). Although 
the recurrence rates are even lower with wide resection, this 
procedure seems to be an overtreatment and is usually not rec-
ommended (Balke and Schremper et al. 2008, Kivioja et al. 
2008).
These findings apply to “typical” tumors that occur in the 
long bones, but occasionally GCTs also arise in the verte-
brae,  pelvis,  and  sacrum  (Campanacci  et  al.  1987,  Osaka 
and Toriyama 1987, Shikata et al. 1992, Sanjay et al. 1993, 
Leggon et al. 2004, Balke et al. 2008b). Optimal treatment for 
these locations is still controversial. The tumors may reach 
remarkable sizes, especially in the pelvis. Due to anatomical 
difficulties such as potential impairment of iliac vessels, the 
bony support of the pelvic ring, the hip joint, and intra-abdom-
inal organs, surgery may be challenging and risky. Thus, alter-
native treatments such as irradiation are taken into account 
although the recurrence rate without surgical removal is high. 
Moreover, there is the risk of radiation-induced secondary sar-
coma (Schwartz et al. 1989, Chakravarti et al. 1999, Leggon 
et al. 2004). Very few publications have specifically addressed 
GCT of the pelvis. To our knowledge, only 3 papers on this 
topic are available in the literature in English (Osaka and Tori-
yama 1987, Sanjay et al. 1993, Leggon et al. 2004). The larg-
est series, with 19 cases treated within a 46-year period, was 
published by Sanjay et al. (1993). 
Here we report on another 20 cases that have been treated 
at a single institution during the past 20 years. We lay spe-
cial emphasis on different treatment modalities with respect to Acta Orthopaedica 2009; 80 (5): 590–596  591
occurrence of local recurrence, pulmonary metastases, func-
tional outcome, and complications.
Methods
243 patients with histologically benign GCT of bone were 
treated at the authors’ institution from 1980 to 2008. 20 of 
these patients (12 women) who presented with GCT of the 
pelvis are included in this study. 16 patients had received the 
initial  treatment  at  our  institution  and  4  patients  had  been 
referred because of estimated recurrence or due to complica-
tions (Table).
The data was retrospectively collected based on information 
from patient records, surgical protocols, and histological and 
radiological findings. The last follow-up was done via per-
sonal or telephone contact.
Most patients were aged between the fourth and sixth decade 
of life at first diagnosis, with a median age of 41 (17–65) years. 
The median follow-up period was 3 (1–11) years. 
Localization
According  to  the  classification  system  by  Enneking  and 
Dunham  (1978)  for  pelvic  tumors,  as  modified  by  Sanjay 
et  al.  (1993),  the  localizations  were  divided  into  3  groups 
(Figure 1): 9 tumors were located in region I (iliosacral), 4 of 
which also showed sacral extension, 5 tumors solely affected 
region III (ischiopubic), and 6 tumors involved the acetabular 
region—referred to as region II.
Concerning the radiological findings, 15 patients presented 
with a stage III lesion, 3 patients presented with a stage II 
lesion, and none of the patients presented with a stage I lesion 
according to Campanacci et al. (1987). The radiographs of 2 
patients were no longer available.
Treatment
The treatment regimens were divided into 5 groups. Group A 
included 8 patients who were treated by intralesional curet-
tage. A small piece of cortical bone was removed to expose 
the lesion and the tumor was curetted through the hole using a 
sharp spoon, and in 3 cases by additional air drill burring. The 
remaining bone was left intact without destruction of the con-
tinuity of the bone. In 6 of these patients, the defect was filled 
with bone cement (Figure 2) and in 2 patients it was filled with 
bone graft. Group B included 5 patients who were treated by 
intralesional resection and extension of the margins by addi-
tional curettage. In contrast to intralesional curettage (group 
A), in these cases the bone mainly affected was resected, lead-
ing to a disruption of the bone continuity. Because the resection 
margins were intralesional, additional curettage (and in 3 cases, 
additional burring) was performed to extend the margins. In 3 
of these patients, the defect was partly (Figure 3) or completely 
filled with bone cement. Group C included 3 patients who were 
treated by wide resection, all located in the ilium (Figure 4). 2 
patients were treated by a combination of external beam irra-
diation (EBI) and surgery, and these are referred to as group D. 
The first patient (case 9) was initially treated by EBI as primary 
treatment but was referred to us after 4 months due to progres-
sion. He was treated by intralesional resection, curettage of 
the margins, and bone cement packing. The second (case 14) 
was treated by curettage and cryotherapy followed by adjuvant 
EBI. Group E included only 1 patient, who was solely treated 
by EBI with proton beam irradiation.
9 patients were also treated by selective arterial emboliza-
tion (SAE) 1 day before surgery to prevent excessive bleeding. 
5 of the tumors were located in region I and 4 in region II. The 
decision for SAE was based on proximity of the tumors to 
major iliac vessels seen on the magnetic resonance images.
Results
No major complication occurred during surgery 
Most tumors with soft tissue extension were located in region 
I (7 of 14). In 3 patients, the information on soft tissue exten-
sion was missing (Table). In 4 cases (2, 8, 12, and 19), his-
tology revealed a secondary aneurysmal bone cyst. 1 patient 
(case 19) had a soft tissue recurrence. The 1 patient who was 
treated solely by EBI (case 15) presented stable disease at the 
last follow-up, 2.5 years after EBI. All other patients had no 
evidence of disease at the last follow-up.
During  the  follow-up  period  no  secondary  sarcoma  was 
detected,  and  none  of  the  patients  developed  pulmonary 
metastases or multicentricity. 
Treatment
Group A: intralesional curettage (8 cases). The most common 
treatment regimen was group A: intralesional curettage fol-
lowed by filling of the defect with bone cement (6 cases) 
(Figure 2). 1 of them (case 3) was referred to us due to local 
infection after biopsy, and was treated by curettage and bone 
Figure 1. Localization of main tumor components. 3 groups according 
to Enneking and Dunham (1978). Region I: iliosacral area; region II: 
acetabular area; region III: ischiopubic area. 9 tumors affected region I, 
6 affected region II, and 5 affected region III. 592  Acta Orthopaedica 2009; 80 (5): 590–596
Data on 20 patients with giant cell tumor of bone
 A  B  C  D  E  F  G  H  I  J  K  L  M  N
  1   M   38  I  Ilium with sacral extension   L   3   +  A   SAE, curettage, burring + PMMA 03/99  –  19  NED 
  2   M   33   I  Ilium with sacral extension   L   3  +  A   SAE, curettage, H2O2, cryotherapy   –  38  NED  +
                    + PMMA 06/95
  3  F  44  I  Ilium  L  3  +  A  Curettage + PMMA 12/89  –  30  NED  +
  4  F  17  I  Ilium  L  n.d.    A  Curettage + bone graft 01/90  –  34  NED  +
  5  F  35  I  Ilium with sacral extension  L  3  +  B  SAE, curettage + PMMA,   –  128  NED 
                    partial sacral resection 09/89
  6  F  35  I  Ilium  R  3  +  C  SAE, wide resection of ilium 11/04  –  33  NED 
  7  M  65  I  Ilium  L  2  +  C  Wide resection of ilium 06/05  –  46  NED  +
  8  M  27  I  Ilium  R  3  +  C  Wide resection of ilium 10/04  –  55  NED  +
  9  F  35  I  Ilium with sacral extension   R  3  nd  D  EBI with 50 Gy 05/97–07/97, SAE, ILR  –  123  NED  +
          and extension to lumbar           + curettage of margins, H2O2 + PMMA 09/97
          spine (L5)
 10  F  57  III–II  Ischiopubis with acetabular  R  3  –  A  SAE, curettage, burring + PMMA 10/00  –  87  NED   +
          extension and path. fracture 
 11  F  43  III–II  Ischium with acetabular  R  3  +  B  SAE, ILR + curettage of margins   –  45  NED   +
          extension           + PMMA 09/05
 12  F  29  III–II  Pubis with acetabular   R  3  +  B  SAE, ILR + curettage of margins   –  112  NED  +
           extension          + hip transposition 02/00
 13  M  31  III–II  Ischium with acetabular    L  3  +  B  SAE, ILR + curettage and  –  22  NED   +
          extension          burring of margins, PMMA 05/05
 14  F  60  III–II  Pubis with acetabular   L  3  +  D  Curettage + cryotherapy + bone graft 10/95,  –  20  NED 
          extension          adjuvant EBI with 50 Gy 01/96–03/96
 15  M  47  III–II  Ischiopubis with acetabular  L  3  +  E  Sole treatment with EBI using proton beam  –  30  SD   +
          extension and soft tissue          radiation 10/04–12/04
          infiltration of adductor muscles
 16  F  38  III  Ischium  L  3  +  A  Curettage, burring and H2O2 + bone graft   –  14  NED 
                    + PMMA 07/00
 17  F  48  III  Pubis  L  n.d.    A  Curettage, phenol + bone graft 01/99  –  13  NED  +
 18  M  52  III  Pubis  L  2  +  A  Curettage, burring + PMMA 08/01  –  72  NED 
 19  F  54  III  Pubis  L  2  –  B  ILR + curettage and burring of margins 04/07  +  25  NED   +
 20  M  59  III  Pubis  R  3  –  B  ILR + curettage and burring of margins   –  12  NED 




D  Region / site of lesion: Grouping of anatomical site (Enneking and Dunham 1978, Sanjay et al. 1993): I, iliosacral; II, ischiopubic with 
acetabular extension; III, ischiopubic.
E  Region / site of lesion
F  Side:  L, left; R, right.
G  Stage
H  Soft tissue extension: –, no; +, yes; n.d., not documented.
I  Grouping of treatment regimen: A, intralesional curettage; B, intralesional resection of mainly affected bone and extension of margins by 
curettage; C, wide resection; D, external beam irradiation (EBI) combined with surgery; E, EBI with proton beam radiation.
J  Treatment: PMMA, polymethyl methacrylate (bone cement); ILR, intralesional resection; SAE, selective arterial embolization; EBI, external 
beam irradiation.
K  Local recurrence: –, no; +, yes.
L  Follow-up (months).
M  Status: NED, no evidence of disease; SD, stable disease; ABC: aneurysmal bone cyst.
N  Comments: +, yes. See below. Case:
2.  Secondary aneurysmal bone cyst.
3.  Referred to us due to local infection after biopsy in another hospital; 3 revisions in 01/99.
4.  Treatment in other hospital, referred to us to exclude recurrence in 10/92.
7.  Limping using a cane.
8.  Secondary aneurysmal bone cyst.
9.   Referred to us 4 months after biopsy and progressive disease. Postoperative impaired wound healing and local infection, resection, and 
hip transposition 10/97, removal of PMMA + debridement 11/97.
10.  Endoprosthesis with acetabular reconstruction in 06/01 due to femoral head necrosis; limping, using 1 cane for longer walks.
11.  Dislocation of screw for PMMA fixation, local pain, removal of screw in 01/09.
12.  Secondary ABC, resection of scar tissue in 04/01, subluxation of femoral head; limping but free from pain; use of cane for longer walks.
13.  Dislocation of screw for PMMA fixation in 08/05, removal of screw; occasionally minimal pain.
15.  Stable disease, additional treatment with oral bisphosphonates, acetabular protrusion.
17.  Treatment in other hospital, referred to us to exclude recurrence in 09/99.
19.  Secondary ABC, soft tissue recurrence treated by wide resection in 04/08; occasionally moderate pain in pubic and gluteal area while sitting.
20.  Surgical excision of sigmoidal gastrointestinal stroma tumor in 01/08; occasionally minimal local pain.Acta Orthopaedica 2009; 80 (5): 590–596  593
cement packing. Another 3 local revisions and 
long-term  antibiotics  were  necessary  to  cure 
the infection. 2 patients (cases 4 and 17) were 
referred with suspected local recurrence. In both 
cases, biopsy revealed scar tissue. 1 patient (case 
10)  presented  with  acetabular  extension  and 
pathological fracture of the acetabulum. He was 
initially treated by curettage and bone cement 
packing  but  developed  femoral  head  necrosis 
with constant hip pain. An endoprosthesis with 
acetabular  reconstruction  became  necessary  8 
months after primary treatment. The patient was 
still dependent on one cane for longer walks, but 
was free from pain at the last follow-up. 
Group  B:  intralesional  resection  with  curet-
tage of margins (6 cases). 1 patient (case 12) was 
treated by a hip transposition (partial resection of 
the pelvis including the acetabulum, proximaliza-
Figure 3. Case 20. a. GCT of the right pubic bone with bony destruction. b. After intralesional resection of pubic 
bone, including the symphysis. Proximal margins were additionally curetted and cemented. Note the multiple 
hemostatic clips. 
Figure 2. Case 2. a. GCT of the left ilium with sacral extension and proximal cortical 
breakthrough. b. After intralesional curettage and bone cement packing of the defect. 
Figure 4. Case 7. a. Giant cell tumor of the left iliac wing. b. After wide resection of the 
left iliac wing without reconstruction.
tion of the femur, and 
refixation of the femo-
ral head with a Trevira 
attachment tube to the 
remaining  iliac  bone 
(Gebert  et  al.  2008)). 
Intralesional  resec-
tion  was  performed  in 
order  to  preserve  the 
acetabulum,  but  was 
not  successful  due  to 
the  extension  of  the 
tumor. 14 months later, 
resection  of  painful 
scar tissue became nec-
essary. At  last  follow-
up, the patient was free 
from pain but was limping and dependent on a 
cane for longer walks, which is typical for this 
type of surgery (Gebert et al. 2008). In 3 patients 
the defect was partly (case 20, Figure 3) or com-
pletely (cases 11 and 13) filled with bone cement. 
In the last 2 cases, the bone cement was secured 
with additional screws to prevent displacement 
(Figure 5). 1 patient with a pubic tumor (case 19) 
developed local recurrence one year after surgery. 
She was primarily treated by intralesional resec-
tion of the pubical bone and additional curettage 
of the margins. The recurrence presented as a 1-
cm soft tissue mass located within the scar tissue 
of the gluteal muscles. It was detected by routine 
control magnetic resonance imaging. The treat-
ment consisted of wide resection. The patient has 
been free from disease for 12 months, but suffers 
from moderate pain in the pubic and gluteal area 
while sitting.594  Acta Orthopaedica 2009; 80 (5): 590–596
Group  C:  wide  resection  (3  cases).  The  3  patients  with 
tumors of region I (cases 6–8) were treated by wide resec-
tion of the iliac wing without reconstruction (Figure 4). 1 of 
the patients is dependent on a cane for longer walks due to 
limping (case 7), but the others did not show any significant 
impairments at the last follow-up. 
Group D: irradiation and surgery (2 cases). The first patient 
(case 9) had a huge tumor of the ilium with extension to the 
sacrum and fifth lumbar vertebra. He had received EBI with 
50 Gy for 3 months at another hospital. Due to progressive 
disease, he was referred to our department. We performed 
intralesional  partial  resection  of  the  ilium  and  sacrum  fol-
lowed by bone cement packing 4 months after biopsy. Due 
to irradiation, wound healing was impaired by local infec-
tion—which was treated by hemipelvectomy (partial resec-
tion of the pelvis (Gebert et al. 2008)) and hip transposition 
1 month later. Another month later, removal of bone cement 
and another debridement was performed. At last follow-up, 
he was dependent on a cane for longer walks and suffered 
from occasional local pain. The second patient (case 14) had a 
tumor of the pubis with acetabular extension. She was treated 
by intralesional curettage with additional cryotherapy, bone 
grafting, and capsular reconstruction with a Trevira attach-
ment tube followed by adjuvant EBI (50 Gy for 3 months). At 
last follow-up after 2 years, she had no signs of disease.
Group E: irradiation alone (1 case). This patient (case 15) 
had a massive tumor of the ischiopubic area with acetabular 
extension  and  soft  tissue  infiltration  of  adductor  muscles. 
He was treated by EBI using proton beam irradiation for 3 
months. At last follow-up 2.5 years later, he presented with 
stable disease. Radiographs show acetabular protrusion of the 
femoral head, which has remained stable over the years. He 
also takes oral bisphosphonates as additional medication. 
Selective arterial embolization
9 patients were treated once by selective arterial embolization 
(SAE) the day before surgery. No complications occurred.
Discussion
Giant cell tumors of bone rarely affect the pelvis. Only 20 
(8%) of our 243 patients with GCT had a tumor of the ilium, 
ischium,  or  pubis,  which  is  in  accordance  with  previous 
reports (Campanacci et al. 1987, Sanjay et al. 1993, Balke et 
al. 2008b). Giant cell tumors have their peak incidence in the 
second and third decades of life (Campanacci 1990, Balke et 
al. 2008b). In a series of 19 patients with GCT of the pelvis, 
Sanjay  et  al.  (1993)  reported  a  peak  age  at  the  third  and 
fourth decades of life (involving 13 of the 19 patients). This 
is supported by our findings; 15 of the 20 patients were aged 
between 30 and 60 years. Thus, GCT of the pelvis appears to 
occur in slightly older patients than the “typical” GCT of the 
extremities.
Almost half of the tumors (9/20) were located in the iliosa-
cral area, which supports the findings of Sanjay et al. (1993). 
It must be admitted that the definition of the anatomical tumor 
region according to Enneking and Dunham (1978) is some-
what subjective. They divided the pelvis into 3 regions: region 
I, the iliosacral area; region II, the acetabular area; and region 
III, the ischiopubic area. In our study, 11 tumors occurred in 
regions II and III, and 6 tumors affected the acetabulum. They 
most likely originated in the ischiopubic bones and extended 
into  the  acetabular  region.  This  is  a  matter  of  definition, 
because it is hardly possible to distinguish whether the tumor 
originated in region III and extends into region II or vice versa. 
Thus, a direct comparison of different studies is difficult. We 
can, however, conclude that tumors affecting the acetabular 
region are more difficult to treat. Compared to the iliac wing, 
wide resection is only possible with major functional impair-
ments (case 12) and intralesional procedures often result in 
secondary complications such as arthritis (case 10) or prob-
lems related to cementation.
Figure 5. Case 11. a. After intralesional resection of a GCT of the 
ischium. Additional curettage and bone cement packing of the ace-
tabular extension was performed. The cement was fixed with 2 screws 
to prevent dislocation. b. CT showing dislocation of the dorsal screw, 
necessitating surgical removal.Acta Orthopaedica 2009; 80 (5): 590–596  595
Leggon et al. (2004) indicated that the local recurrence rate 
for GCT of the pelvis and sacrum seems higher than for any 
other location. In the study by Sanjay et al. (1993), 6 of 19 
pelvic tumors developed local recurrence. In our series, the 
recurrence rate of 1 in 20 is low. Since 3 (14) of our patients 
had a shorter follow-up than 2 (4) years, we cannot exclude the 
possibility that there might be further recurrences with longer 
follow-up, but 70% of local recurrences occur within the first 2 
years (Balke et al. 2008a). The seemingly low recurrence rate in 
our patients may have been caused by several factors. 3 patients 
were treated by wide resection, which has been reported to pre-
vent recurrences (Balke et al. 2008a, b), and 6 were treated by 
intralesional resection of the bone that was mainly affected. 
Thus, almost half of the patients were treated by presumably 
more complete tumor removal than with “typical” curettage 
alone, which is the recommended treatment for GCT of the 
extremities. Apart from this, 2 patients also received irradia-
tion and 9 patients embolization, which might also reduce the 
recurrence  rate.  Interestingly,  the  only  recurrence  occurred 
within the soft tissue of the surgical tract after former intra-
lesional resection. It would probably be more appropriate to 
define it as left-over soft tissue extension from the first opera-
tion rather than local recurrence. It is remarkable that such a 
recurrence occurs so rarely, although the surgical tract is often 
contaminated after intralesional procedures. We have not found 
any literature specifically addressing this topic. 
9 of our patients were treated by SAE on the day before sur-
gery, to prevent excessive intraoperative bleeding. The deci-
sion was made when the magnetic resonance images showed 
proximity of the tumor to major iliac vessels. The low recur-
rence rate in our series might also be—at least in part—an 
effect of the SAE (Misasi and Sadile 1991). In a study by Lin 
et al. (2002), 18 patients with GCT of the sacrum were treated 
with repeated intra-arterial embolization as the sole treatment. 
Half of the patients showed a durable radiographic response 
at median 9 years of follow-up. In a study by Hosalkar et al. 
(2007), 9 patients underwent angiography and selective arte-
rial embolization at the time of diagnosis, followed by repeated 
embolization. No progression was noted in 7 of 9 cases at a 
mean follow-up of 9 years. It may be that presurgical selective 
arterial embolization not only prevents bleeding but also plays 
a role as an adjuvant in the treatment of large tumors.
 The rate of grade III tumors (15/19) was higher than in 
patients with other locations (Campanacci et al. 1987, Tur-
cotte et al. 2002, Balke et al. 2008b). Diagnosis of tumors in 
the pelvis may be delayed compared to tumors of the long 
bones. The clinical presentation is mostly uncharacteristic and 
may be confused with low back pain, arthritis, muscle strain, 
or strain of the iliosacral joint (Sanjay et al. 1993, Leggon et 
al. 2004). An external swelling is not visible until late, and 
radiographs are often misinterpreted; the osteolytic lesion of 
the tumor may be confused with gas-filled intestines or may 
be covered by shielding of ovaries or testes. This may explain 
the high rate of soft tissue extension (14/17). The other pub-
lications on GCT of the pelvis have not provided information 
about soft tissue extension (Osaka and Toriyama 1987, Sanjay 
et al. 1993, Leggon et al. 2004). The rate of secondary aneu-
rysmal bone cysts in our patients seems to be relatively high 
(4/20). This is probably due to the size of the tumors and to the 
rich vascularization of the pelvis compared to the extremities.
 The role of external beam irradiation (EBI) in the treatment 
of GCT is still a matter for discussion. It is used as primary 
or adjuvant treatment, but is accompanied by a high risk of 
inducing secondary sarcomas. The reported rates range from 
7% to 25% (Johnson and Riley 1969, Sanerkin 1980, Rock et 
al. 1986). In the study by Sanjay et al. (1993), 8 patients with 
GCT of the pelvis received EBI; 2 of them developed a post-
irradiation sarcoma 7 and 13 years later. In the review of the 
literature of pelvic and sacral GCT by Leggon et al. (2004), 
radiation-induced sarcoma occurred in 11% of patients who 
received radiation therapy for a primary or recurrent lesion at 
a follow-up of 5 years. The risk increases with time, so that the 
rate might be even higher with a longer follow-up (Tucker et al. 
1987). In our study, 3 patients were treated with EBI. To date, 
none of the patients have developed a secondary sarcoma but 
the follow-up period is too short for final evaluation. We agree 
with Sanjay et al. (1993) that EBI is not to be recommended 
when an operation is a reasonable alternative. Although this is 
the largest published series of GCT of the pelvis, the numbers 
are too small for statistical analysis of different treatment regi-
mens. However, we hope that this work will help in decision 
making when addressing treatment of these tumors. Because 
GCTs of the pelvis are extremely rare, more reliable results 
can probably only be obtained by using a multi-center study. 
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